Rezolute Inc
General ticker "RZLT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $336.1M
Rezolute Inc follows the US Stock Market performance with the rate: 51.5%.
Estimated limits based on current volatility of 3.5%: low 4.19$, high 4.49$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [2.89$, 7.04$]
- 2025-06-30 to 2026-06-30 estimated range: [1.95$, 5.04$]
Financial Metrics affecting the RZLT estimates:
- Negative: Non-GAAP EPS, $ of -1.33 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -19.71 <= 2.35
- Negative: negative Net income
Short-term RZLT quotes
Long-term RZLT plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $41.84MM | $55.99MM | $70.42MM |
| Operating Income | $-41.84MM | $-55.99MM | $-70.42MM |
| Non-Operating Income | $0.78MM | $4.20MM | $1.96MM |
| Interest Expense | $1.81MM | $0.00MM | $0.00MM |
| R&D Expense | $32.49MM | $43.81MM | $55.74MM |
| Income(Loss) | $-41.06MM | $-51.79MM | $-68.46MM |
| Profit(Loss) | $-41.06MM | $-51.79MM | $-68.46MM |
| Stockholders Equity | $149.47MM | $116.17MM | $121.00MM |
| Assets | $152.42MM | $123.72MM | $132.74MM |
| Operating Cash Flow | $-39.62MM | $-44.48MM | $-57.37MM |
| Capital expenditure | $0.00MM | $0.15MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-101.46MM | $48.70MM |
| Financing Cash Flow | $148.98MM | $11.57MM | $63.03MM |
| Earnings Per Share* | $-2.13 | $-1.01 | $-1.33 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.